The HHS Office of Inspector General (OIG) has issued two reports regarding Part D drugs for dual-eligible nursing home residents: “Availability of Medicare Part D Drugs to Dual-Eligible Nursing Home Residents,” and “Role of Nursing Homes and Long Term Care Pharmacies in Assisting Dual-Eligible Residents With Selecting Part D Plans.”